NANOBIOTIX EXPANDING LIFE
LIVE

Serial Number

79447234

Owner

NANOBIOTIX

Attorney

Vivian Ortiz-Ponce

Filing Date

Feb 6, 2026

Add to watchlist:

No watchlists yet
View on USPTO

NANOBIOTIX EXPANDING LIFE Trademark

Serial Number: 79447234

NANOBIOTIX EXPANDING LIFE is a trademark filed by NANOBIOTIX on February 6, 2026. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently pending registration.

Owner Contact Info

NANOBIOTIX (30 trademarks)

60 rue de Wattignies

Entity Type: 99

Trademark Details

Filing Date

February 6, 2026

Registration Date

Not Registered

Goods & Services

Medical devices using nanoparticles for therapeutic or diagnostic purposes, namely, for treating tumors; Medical instruments for delivering or activating therapeutic substances for treating cancerous tumors; Medical devices for combination with ionizing radiation for diagnosis and therapy of cancerous tumors; surgical and medical devices and instruments for deep brain stimulation, electrical transcranial stimulation, transcranial direct-current stimulation, transcranial magnetic stimulation, any form of electromagnetic light, magnetic field, electric field stimulation, radio frequency or ultrasound stimulation; medical apparatus containing electrodes, electroencephalograph, micro-electrode arrays for the recording of electrical brain activity; medical apparatus for neuronal modeling;

Chemical preparations for medical use for the diagnosis and treatment of cancerous tumors; Radiosensitizing pharmaceutical agents for making cancerous tissues more sensitive to radiation therapy; Pharmaceutical preparations for the targeted delivery of active ingredients for treating cancer; Contrast agents for use in MRI, X-ray computed tomography, ultrasound, X-ray and angiography and nuclear imaging; Preparations for medical use, namely, for modifying the bioavailability of therapeutic agents; Preparations for medical use for modifying liver functions; Pharmaceutical preparation based on nanomaterials for the delivery of therapeutic agents for treating cancer; Products for medical use, namely pharmaceuticals for the treatment of brain diseases and disorders; pharmaceutical preparations for the diagnosis and treatment of brain diseases and disorders; Preparations for medical use particularly for the treatment of Parkinson's disease, Alzheimer's disease, epilepsy and all types of neurological and neuropsychiatric diseases and disorders; pharmaceutical preparations for the diagnosis and treatment of neurological disorders and diseases using deep brain stimulation, electrical transcranial stimulation, transcranial direct-current stimulation, transcranial magnetic stimulation, any form of electromagnetic light, magnetic field, electric field stimulation, radio frequency or ultrasound stimulation; Diagnostic products, namely, diagnostic reagents for medical use; Drugs for medical use, namely, pharmaceutical preparations for treating cancer;

Filing History

TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 11, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 11, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 11, 2026 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 10, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 10, 2026 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 10, 2026 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sep 10, 2026 COAR
REFUSAL PROCESSED BY IB
Aug 13, 2026 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 24, 2026 RFCS
REFUSAL PROCESSED BY MPU
Jul 24, 2026 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 7, 2026 RFCR
NON-FINAL ACTION WRITTEN
Jun 5, 2026 CNRT
ASSIGNED TO EXAMINER
Jun 3, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Apr 3, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 3, 2026 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 2, 2026 REPR